GORYO CHEMICAL, INC published a study in Cell Metabolism showing that colorectal cancer cells use an adaptive metabolic program to buffer iron-driven oxidative stress.
Public source
Publisher name
Public post
Colorectal cancer cells evade iron-induced death by co-opting a heme–mitochondrial complex II–CoQ defense axis. In a recent study published in Cell Metabolism, the autho…
Company
GORYO CHEMICAL, INC
Creating unique fluorescence probes for research
- Industry
- Biotechnology Research
- Location
- Sapporo, JP
- Company size
- 2–10 employees
About GORYO CHEMICAL, INC
GORYO Chemical, Inc. provides new fluorescent probes for cellular analysis, assay, and imaging. AcidiFluor™ ORANGE is a fluorescence imaging probe which enhances fluorescence dramatically in acidic environments. This probe can selectively stain acidic organelles such as lysosome, late endosomes and granules. Its has excellent selectivity enabling it to detect acidic environments. At pH 5.0, identical to the environment of acidic organelles, the fluorescence intensity is 50-fold or more compared to pH 7.4. AcidiFluor™ ORANGE shows excellent photostability to excitation light. CaSiR-1™ and CaSiR-1™ AM are near-infrared fluorescence calcium probes which have fluorescence maximum wavelength at 664 nm. Multicolor imaging is possible between CaSiR-1™ or CaSiR-1™ AM and fluorescent probes or fluorescent proteins which have fluorescent wavelength in visible range such as Hoechst, Fluorescein, Rhodamine, GFP, YFP and RFP etc. The near-infrared region has greater tissue penetration, less overlap with the spectrum of background autofluorescence and exhibits less phototoxicity to cells and tissue. GlycoYELLOW™-βGal is a specific fluorescent probe for detection of β-galactosidase. It can be used in fluorescent imaging and identification of cells and tissue transfected with lacZ. Because GlycoYELLOW™-βGal is almost non-fluorescent in the absence of β-galactosidase, this probe exhibits an excellent S/N ratio.
See moreLatest activity
Latest activity from GORYO CHEMICAL, INC
6 signals
Research & Knowledge
GORYO CHEMICAL, INC published a study in Mitochondrion exploring the relationship between primary mitochondrial disease, intracellular iron, and ferroptosis sensitivity.
Research & Knowledge
GORYO CHEMICAL, INC published a study in Cell showing that NFS1-dependent sulfur metabolism is critical for CD8⁺ T cell proliferation and anti-tumor function.
Research & Knowledge
Goryo Chemical, Inc published a study in Molecules revealing that agapanthussaponin A, a natural product isolated from Agapanthus africanus, induces apoptosis and ferroptosis in small-cell lung cancer cells.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
MedChemExpress LLC
MedChemExpress LLC published a study finding that mutant KRAS can reshape the tumor microbiome and enrich Bacteroides acidifaciens.
Research & Knowledge
Lucid Scientific
Lucid Scientific published new research from Mirna Mina-Abouda, Joe Delaney, and the MUSC Hollings Cancer Center team showing that losing metallothionein 2A in high-grade serous ovarian tumors leads to mutations, DNA repair impairment, and mitochondrial dysfunction.
Research & Knowledge
G-Biosciences
G-Biosciences cited its BLOT-QuickBlocker in a CRISPR activation screen identifying BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity in Nature Communications.
Research & Knowledge
Promega Corporation
Promega Corporation published a new study suggesting that metabolic reprogramming with small molecule DCA might help limit the exhaustion of engineered T cells.
Research & Knowledge
Crown Bioscience